ondansetron has been researched along with vortioxetine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang-Andersen, B; Frederiksen, K; Hogg, S; Jensen, KG; Jørgensen, M; Mørk, A; Nielsen, SM; Ruhland, T; Smith, G; Stensbøl, TB; Zhong, H | 1 |
| Bang-Andersen, B; Boyle, NJ; Brennum, LT; Bundgaard, C; Fischer, CW; Hogg, S; Lassen, AB; Liebenberg, N; Miller, S; Mørk, A; Nielsen, SM; Pehrson, A; Sánchez, C; Stensbøl, TB; Wegener, G; Westrich, L; Zhong, H | 1 |
| Dale, E; Ebert, B; Frederiksen, K; Grunnet, M; Jensen, TN; Larsen, PH; Liu, H; Lu, D; Nielsen, J; Pehrson, AL; Sanchez, C; Stensbøl, TB; Yang, CR; Yin, H | 1 |
| Brouard, JT; Li, Y; Sánchez, C; Schweimer, JV; Sharp, T | 1 |
4 other study(ies) available for ondansetron and vortioxetine
| Article | Year |
|---|---|
Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Topics: Animals; Antidepressive Agents; Cell Line; Depressive Disorder, Major; Drug Partial Agonism; Drug Stability; Hippocampus; Humans; In Vitro Techniques; Microsomes, Liver; Oocytes; Piperazines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfides; Vortioxetine; Xenopus | 2011 |
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.
Topics: Animals; Anti-Anxiety Agents; Biogenic Monoamines; Citalopram; Depressive Disorder, Major; Humans; Male; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reflex; Serotonin Plasma Membrane Transport Proteins; Sulfides; Vocalization, Animal; Vortioxetine | 2012 |
The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
Topics: Action Potentials; Animals; Antidepressive Agents; CA1 Region, Hippocampal; Dogs; gamma-Aminobutyric Acid; Glutamic Acid; Guinea Pigs; HEK293 Cells; Humans; Interneurons; Mice; Ondansetron; Oocytes; Pyramidal Cells; Rats; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Tissue Culture Techniques; Vortioxetine; Xenopus laevis | 2018 |
In vivo electrophysiological study of the targeting of 5-HT
Topics: Animals; Antidepressive Agents; Interneurons; Ondansetron; Piperazines; Rats; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Sulfides; Vortioxetine | 2022 |